Last Posted: Jul 03, 2022
- Can breast cancer prevention strategies be tailored to biologic subtype and unique reproductive windows?
Schedin Pepper et al. Journal of the National Cancer Institute 2022 6 - Impact of artificial intelligence in breast cancer screening with mammography.
Dang Lan-Anh et al. Breast cancer (Tokyo, Japan) 2022 - A systematic literature review of the management, oncological outcomes and psychosocial implications of male breast cancer.
Rutherford C L et al. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2022 - Breast Cancer with Low Recurrence Score on Oncotype DX: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation.
Zarbiv Yonaton et al. Oncology and therapy 2022 - Chemotherapy Regimens Received by Women with BRCA1/2 Pathogenic Variants for Early-Stage Breast Cancer Treatment.
Kurian Allison W et al. JNCI cancer spectrum 2022 - Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk.
Henderson Vida et al. BMC health services research 2022 22(1) 826 - Talking about Risk, UncertaintieS of Testing IN Genetics (TRUSTING): development and evaluation of an educational programme for healthcare professionals about BRCA1 & BRCA2 testing.
Fallowfield Lesley et al. British journal of cancer 2022 - The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy.
Sella Tal et al. Breast cancer research and treatment 2022 - A Decisive Metaheuristic Attribute Selector Enabled Combined Unsupervised-Supervised Model for Chronic Disease Risk Assessment.
Mishra Sushruta et al. Computational intelligence and neuroscience 2022 20228749353 - Predicting breast cancer recurrence and metastasis risk by integrating color and texture features of histopathological images and machine learning technologies.
Liu Xinyu et al. Computers in biology and medicine 2022 146105569
More
Search Result Summary
- CDC Information (19)
- NIH Information (17)
- CDC Publications (10)
- COVID-19 (46)
- Human Genome Epidemiologic Studies (7192)
- GWAS Studies (120)
- Human Genomics Translation/Implementation Studies (2134)
- Genomic Tests Evidence Synthesis (187)
- Genomic Tests Guidelines (85)
- Tier-Classified Guidelines (35)
- Non-Genomics Precision Health (243)
- Pathogen Advanced Molecular Detection (3)
- State Public Health Genomics Programs (118)
- Ethical/Legal and Social Issues (ELSI) (30)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2021
- Page last updated:Jul 03, 2022
- Content source: